Gemcitabine-induced Chronic Systemic Capillary Leak Syndrome: a Life-threatening Disease
Overview
Affiliations
Cancer therapy-related interstitial lung disease.
Zhou C, Deng H, Yang Y, Wang F, Lin X, Liu M Chin Med J (Engl). 2024; 138(3):264-277.
PMID: 39402974 PMC: 11771665. DOI: 10.1097/CM9.0000000000003149.
Systemic Capillary Leak Syndrome (SCLS) Presentation in Patients Receiving Anti-cancer Treatments.
Anipindi M, Kacarow J, Bitetto D Cureus. 2023; 15(4):e38335.
PMID: 37261188 PMC: 10228707. DOI: 10.7759/cureus.38335.
Anticancer Drug-Induced Capillary Leak Syndrome.
Izzedine H, Mathian A, Amoura Z, Ng J, Jhaveri K Kidney Int Rep. 2022; 7(5):945-953.
PMID: 35570987 PMC: 9091576. DOI: 10.1016/j.ekir.2022.02.014.
Chronic idiopathic systemic capillary leak syndrome: a case report.
Alkhunaizi A, Kabbani A, ElTigani M Allergy Asthma Clin Immunol. 2019; 15:34.
PMID: 31160895 PMC: 6540441. DOI: 10.1186/s13223-019-0347-0.
Gemcitabine-induced chronic systemic capillary leak syndrome.
Bajwa R, Starr J, Daily K BMJ Case Rep. 2017; 2017.
PMID: 28855215 PMC: 5589048. DOI: 10.1136/bcr-2017-221068.